Antitumor Effects of Eribulin Mesylate in Gemcitabine-resistant Pancreatic Cancer Cell Lines

作者:Takezaki Yuka; Namikawa Tsutomu; Koyama Tsuyoshi; Munekage Eri; Munekage Masaya; Maeda Hiromichi; Kitagawa Hiroyuki; Hanazaki Kazuhiro
来源:Anticancer Research, 2016, 36(11): 6077-6082.
DOI:10.21873/anticanres.11197